TY - CONF
T1 - Efficacy and safety of dupilumab in children aged 6-11 years with inadequately controlled severe atopic dermatitis: results from an open-label extension trial up to 1 year
JO - BRITISH JOURNAL OF DERMATOLOGY
PY - 2022/01/01
AU - Paller AS
AU - Cork MJ
AU - Siegfried EC
AU - Guttman-Yassky E
AU - Simpson EL
AU - Soong W
AU - Xiao J
AU - Wang Z
AU - Chuang C-C
AU - O'Malley JT
AU - Bansal A
ED -
VL - 186
IS - 4
SP - E159
EP - E160
Y2 - 2025/07/13
ER -